Hypercholesterolemia: Clinical Trials

6 trials for Hypercholesterolemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 terminated. 6 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 26Terminated 6
Phase 11Terminated 1

Follow Hypercholesterolemia: new trials by email Literature Review of Hypercholesterolemia trials Research Report on Hypercholesterolemia

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism
Adrenalectomy, Observation - Subclinical Hypercortisolism, Cushing Syndrome
Phase 2TerminatedNational Cancer Institute (NCI)42013-11-272018-06-14
Efficacy of Lapaquistat Acetate in Subjects With Hypercholesterolemia
Lapaquistat acetate, Placebo - Hypercholesterolemia
Phase 2TerminatedTakeda2242007-07-012012-05-24
A Randomized, Double-Blind, Placebo-Controlled Study to Examine the Effect of Betahistine on Plasma Lipids in Patients Treated With Simvastatin
Betahistine - Hypercholesterolemia
Phase 2TerminatedOBEcure Ltd.302007-05-012007-09-26
Statins to Reduce D-dimer Levels in Patients With Venous Thrombosis
atorvastatin, diet - Venous Thromboembolism, Hypercholesterolemia
Phase 2TerminatedUniversità degli Studi dell'Insubria102007-05-012011-08-19
MK0859 Dose-Ranging Study (0859-003)
MK0859 - Hypercholesterolemia, Mixed Hyperlipemia
Phase 2TerminatedMerck Sharp & Dohme LLC5002006-06-012015-03-02
Study of 3,5-Diiodothyropropionic Acid (DITPA) in Hypercholesterolemic Patients
3,5-Diiodothyropropionic acid (DITPA) therapy - Hypercholesterolemia
Phase 1 / Phase 2TerminatedJohns Hopkins University602006-04-012013-04-02

Narrower conditions

Adrenal Gland Neoplasms (1)  ·  Adrenal incidentaloma (1)  ·  Cushing Syndrome (1)  ·  Diabetes Mellitus (1)  ·  Dyslipidemias (1)  ·  Hyperlipidemias (1)  ·  Hyperlipoproteinemia Type V (1)  ·  Hypertension (1)  ·  Obesity (1)  ·  Osteoporosis (1)  ·  Venous Thromboembolism (1)

Broader conditions

Lipid Metabolism Disorders (6)  ·  Metabolic Diseases (6)  ·  Nutritional and Metabolic Diseases (6)  ·  Dyslipidemias (5)  ·  Hyperlipidemias (5)  ·  Cardiovascular Diseases (2)  ·  Vascular Diseases (2)  ·  Adrenal Gland Diseases (1)  ·  Adrenocortical Hyperfunction (1)  ·  Body Weight (1)  ·  Bone Diseases (1)  ·  Bone Diseases, Metabolic (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Embolism and Thrombosis (1)  ·  Endocrine Gland Neoplasms (1)

Interventions

1-((1-(3-acetoxy-2,2-dimethylpropyl)-7-chloro-5-(2,3-dimethoxyphenyl)-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl)acetyl)piperidine-4-acetic acid (1)  ·  3,5-diiodothyropropionic acid (1)  ·  Adrenalectomy (1)  ·  Atorvastatin (1)  ·  Betahistine (1)  ·  Diet (1)  ·  Observation (1)  ·  Therapeutics (1)  ·  anacetrapib (1)

Sponsors

Johns Hopkins University (1)  ·  Merck Sharp & Dohme LLC (1)  ·  National Cancer Institute (NCI) (1)  ·  OBEcure Ltd. (1)  ·  Takeda (1)  ·  Università degli Studi dell'Insubria (1)

Countries

United States (3)  ·  Israel (1)  ·  Italy (1)

Top investigators

Annabelle Rodriguez, MD (1)  ·  Davide Imberti (1)  ·  Dhaval T Patel, M.D. (1)  ·  Gualtiero Palareti (1)  ·  Walter Ageno (1)  ·  Yaffa Beck, Dr. (1)

Results publications

PMID 21982664, PMID 25670366, PMID 25968622